Volume | 266,354 |
|
|||||
News | - | ||||||
Day High | 28.38 | Low High |
|||||
Day Low | 26.585 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Arcturus Therapeutics Holdings Inc | ARCT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
28.20 | 26.585 | 28.38 | 26.98 | 27.93 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
7,254 | 266,354 | $ 27.34 | $ 7,281,318 | - | 17.52 - 43.81 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:11:36 | formt | 618 | $ 26.98 | USD |
Arcturus Therapeutics (ARCT) Options Flow Summary
Arcturus Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
725.9M | 26.92M | - | 166.8M | -29.73M | -1.10 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Arcturus Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 30.25 | 30.89 | 25.57 | 26.86 | 499,405 | -3.27 | -10.81% |
1 Month | 32.37 | 33.99 | 25.57 | 30.53 | 517,009 | -5.39 | -16.65% |
3 Months | 32.46 | 43.81 | 25.57 | 34.79 | 495,667 | -5.48 | -16.88% |
6 Months | 19.55 | 43.81 | 17.52 | 30.50 | 454,111 | 7.43 | 38.01% |
1 Year | 27.72 | 43.81 | 17.52 | 29.70 | 432,072 | -0.74 | -2.67% |
3 Years | 36.39 | 64.9735 | 11.70 | 29.13 | 537,794 | -9.41 | -25.86% |
5 Years | 7.27 | 129.71 | 5.70 | 39.52 | 560,684 | 19.71 | 271.11% |
Arcturus Therapeutics Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. |